Table 1.
Group | Example | Lesion location | Preferred population | Vascular complication | Risk factor |
---|---|---|---|---|---|
Large vessel | Giant cell arteritis | Aorta and major branches |
Caucasian, >50 y/o | Accelerated atherosclerosis high aortic aneurysms but low IMT |
Diabetes, hypertension, high c-reactive protein (CRP) and autoantibody titters |
Takayasu arteritis | Aorta, pulmonary, coronary, and cervical arteries |
Young women 15–45 y/o Asian Latin Americans |
Accelerated atherosclerosis vasa vasorum EC injury thrombus formation thoracic dilatation, rupture |
Viral infection and genetic factor | |
Medium-sized vessel | Kawasaki disease | Subclavian, mesenteric, iliac, temporal arteries |
Infants and <5 y/o Asian Latin Americans |
Coronary artery dilatation cardiac failure high IMT and arterial stiffness |
Diabetes, hypertension, high CRP, autoantibody titters |
Polyarteritis Nodosa | Temporal arteries and medium-to-small muscular arteries in kidney, gastrointestinal tract, skin, nerve, joint, and muscle |
Children and adults affected with hepatitis B or HIV or streptococcal virus |
Unknown relationship with atherosclerosis |
Viral infection | |
Small vessel | Grouped according to whether they contain ANCA (anti-neutrophil cytoplasmic autoantibody) |
Small arteries in skin, intestine, kidney. respiratory tract, or any other organs |
Children and adults affected with hepatitis C |
CVD as a major cause of mortality in ANCA+ patients, arterial stiffness, and impaired vasodilatation |
Viral infection, diabetes, hypertension, impaired renal function, high CRP level and high autoantibody titters |